The relevance of the Siewert classification in the era of multimodal therapy for adenocarcinoma of the gastro-oesophageal junction

MLA

Fergus Noble, et al. “The Relevance of the Siewert Classification in the Era of Multimodal Therapy for Adenocarcinoma of the Gastro-Oesophageal Junction.” Journal of Surgical Oncology, vol. 109, no. 3, Nov. 2013, pp. 202–07. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e9231619913bd992fb3370088513db4f&authtype=sso&custid=ns315887.

APA

Fergus Noble, Timothy J. Underwood, Jamie Kelly, Ian Bailey, James P. Byrne, & Nathan J. Curtis. (2013). The relevance of the Siewert classification in the era of multimodal therapy for adenocarcinoma of the gastro-oesophageal junction. Journal of Surgical Oncology, 109(3), 202–207.

Chicago

Fergus Noble, Timothy J. Underwood, Jamie Kelly, Ian Bailey, James P. Byrne, and Nathan J. Curtis. 2013. “The Relevance of the Siewert Classification in the Era of Multimodal Therapy for Adenocarcinoma of the Gastro-Oesophageal Junction.” Journal of Surgical Oncology 109 (3): 202–7. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e9231619913bd992fb3370088513db4f&authtype=sso&custid=ns315887.